Core Viewpoint - H&H International Holdings (01112) reported a 5% year-on-year increase in total revenue for H1 2025, amounting to 7.019 billion yuan, with adjusted comparable EBITDA decreasing by 3% to 1.101 billion yuan, and adjusted comparable net profit increasing by 5% to 363 million yuan. The company is expected to see EPS of 0.79, 1.05, and 1.30 yuan for 2025-2027, with a "Buy" investment rating assigned by Huaxin Securities [1]. Revenue and Profitability - The company experienced a year-on-year revenue increase, with a notable improvement in gross margin. The gross margin for H1 2025 rose by 2 percentage points to 62.53%, driven by higher margins in adult and pet nutrition and care products, along with product mix optimization [1]. - The proportion of sales and distribution/administrative expenses relative to revenue increased by 3 percentage points and decreased by 0.4 percentage points to 42.33% and 5.68%, respectively, due to changes in the channel mix for adult nutrition and care products in mainland China and investments in new market expansion strategies [1]. - Adjusted comparable EBITDA margin and adjusted comparable net profit margin decreased by 1 percentage point and 0.02 percentage points to 15.68% and 5.17%, respectively, primarily due to high base effects from the previous year and increased selling expenses [1]. Business Segment Performance - The adult nutrition and care products segment saw a 5% year-on-year revenue increase to 3.439 billion yuan, largely attributed to the outstanding performance of Swisse's innovative anti-aging product line, which grew by 39% compared to the benchmark [2]. - Revenue from infant nutrition and care products increased by 3% year-on-year to 2.501 billion yuan, driven by effective e-commerce channel development and new mother education initiatives in specialty stores. The company successfully transitioned its products to meet new national standards, with the market share of its premium infant formula brand reaching a historical high of 15.9% [2]. - The pet nutrition and care products segment experienced a 10% year-on-year revenue increase to 1.079 billion yuan, with gross margin rising by 12 percentage points to 58.70%. This growth was supported by deepened partnerships in North America and the ongoing high-end upgrade of Solid Gold in mainland China, leading to significant improvements in profitability [2]. Regional and Channel Insights - Revenue from mainland China increased by 9% year-on-year to 4.936 billion yuan, driven by strong growth in adult nutrition and care products and rapid channel expansion. Cross-border e-commerce revenue grew by 18%, with Douyin channel revenue surging by 80%, becoming a key growth engine [3]. - Revenue from Australia and New Zealand decreased by 18% to 801 million yuan, primarily due to a decline in corporate purchasing business [3]. - North American revenue increased by 6% to 862 million yuan, benefiting from the popularity of premium pet nutrition products and a growing pet population, with major retailers like Amazon, Walmart, and PerSmart performing well [3]. - Other regions saw a 17% year-on-year revenue increase to 420 million yuan, with strong growth in the Asian expansion market [3].

Core Viewpoint - H&H International Holdings reported a total revenue of 7.019 billion yuan for H1 2025, reflecting a 5% year-on-year increase, with adjusted comparable EBITDA of 1.101 billion yuan, down 3% year-on-year, and adjusted comparable net profit of 363 million yuan, up 5% year-on-year. The company is expected to see EPS of 0.79, 1.05, and 1.30 yuan for 2025-2027, with a "Buy" investment rating assigned by Huaxin Securities [1]. Revenue and Profitability - The company achieved a gross margin increase of 2 percentage points to 62.53% in H1 2025, driven by improved margins in adult and pet nutrition and care products, along with product mix optimization [1]. - The proportion of sales and distribution/administrative expenses to revenue increased by 3 percentage points and decreased by 0.4 percentage points to 42.33% and 5.68%, respectively, due to changes in the channel mix for adult nutrition and care products in mainland China and investments in new market expansion strategies [1]. - Adjusted comparable EBITDA margin and adjusted comparable net profit margin decreased by 1 percentage point and 0.02 percentage points to 15.68% and 5.17%, respectively, primarily due to high base effects from the previous year and increased selling expenses [1]. Business Segment Performance - In H1 2025, revenue from adult nutrition and care products increased by 5% to 3.439 billion yuan, largely due to the outstanding performance of Swisse's innovative anti-aging product line, which saw a 39% growth compared to the benchmark [2]. - Revenue from infant nutrition and care products rose by 3% to 2.501 billion yuan, supported by effective e-commerce channel development and educational initiatives for new mothers in specialty stores, with the product successfully transitioning to new national standards [2]. - Revenue from pet nutrition and care products increased by 10% to 1.079 billion yuan, with gross margin rising by 12 percentage points to 58.70%, driven by deepened North American channel cooperation and the ongoing high-end upgrade of Solid Gold in mainland China [2]. Regional and Channel Insights - Revenue from mainland China in H1 2025 grew by 9% to 4.936 billion yuan, primarily due to strong growth in adult nutrition and care products and rapid channel expansion, with cross-border e-commerce revenue increasing by 18% and Douyin channel revenue surging by 80% [3]. - Revenue from Australia and New Zealand decreased by 18% to 801 million yuan, mainly due to a decline in corporate purchasing business [3]. - North American revenue increased by 6% to 862 million yuan, benefiting from the popularity of high-end pet nutrition products and the growing pet population, with major retailers like Amazon and Walmart performing well [3]. - Other regions saw a revenue increase of 17% to 420 million yuan, with strong growth in the Asian expansion market [3].

Investment Rating - The report maintains a "Buy" rating for H&H International Holdings (1112.HK) [1][4] Core Views - The company's performance in the first half of 2025 met previous forecasts, with revenue of HKD 7.02 billion, a year-on-year increase of 4.9% [4] - The report highlights the continuous market share growth of the company's infant formula brand, with a significant increase in the ultra-premium segment in mainland China [4] - The report projects total revenue for 2025-2027 to be HKD 14.37 billion, HKD 15.49 billion, and HKD 16.44 billion respectively, with net profit estimates of HKD 676 million, HKD 845.5 million, and HKD 952.9 million [1][4] Revenue and Profit Analysis - In the first half of 2025, the revenue from the ANC (Adult Nutrition and Care) business was HKD 3.44 billion, up 5.0% year-on-year, with mainland China contributing HKD 4.94 billion, a growth of 8.7% [4] - The BNC (Baby Nutrition and Care) segment achieved revenue of HKD 2.50 billion, a 2.9% increase, with a notable 10.0% growth in mainland China [4] - The PNC (Pet Nutrition and Care) business reported revenue of HKD 1.08 billion, reflecting a 9.6% increase, driven by a successful high-end strategy [4] Financial Forecasts - The report forecasts total revenue for 2024A at HKD 13.05 billion, with a projected growth rate of -6.3% [5] - The estimated diluted earnings per share for 2025E is HKD 1.05, with a P/E ratio of 13.27 based on the current price [5] - The report maintains the target price at HKD 16.9, indicating potential upside from the current market price [4][5]

Core Insights - H&H International Holdings Limited reported a 5.2% year-on-year revenue growth to 7.02 billion yuan in the first half of 2025, with the Chinese market contributing 70.3% of total revenue and growing by 8.7% [1] - The company focuses on providing nutrition and health products for families, with all three major business segments—Adult Nutrition and Care (ANC), Baby Nutrition and Care (BNC), and Pet Nutrition and Care (PNC)—showing revenue growth and maintaining a stable adjusted EBITDA margin of 15.7% [1] Business Segment Performance - ANC revenue reached 3.44 billion yuan, up 5.9% year-on-year, with the Chinese market growing by 13.1%. Swisse brand saw a remarkable 38.7% growth, driven by its "Swisse Mega Brand" strategy and expansion into high-end anti-aging products [2] - BNC revenue grew by 2.9% to 2.5 billion yuan, with a 10.0% increase in sales of infant formula in mainland China, significantly outperforming the overall market growth of 0.2%. The market share of the premium infant formula brand, 合生元, increased to 15.9% [3] - PNC revenue reached 1.08 billion yuan, up 8.6%, with high-end pet supplements growing by 14.3%. The brand Solid Gold successfully optimized its channels and product offerings, achieving a 17.5% sales increase [3] Strategic Initiatives - The company plans to enhance innovation and implement a family nutrition health strategy, focusing on different demographic needs. In ANC, it aims to solidify its market position in mainland China and expand into Southeast Asia, India, the Middle East, and Italy [4] - For BNC, the company will leverage e-commerce and maternal channels to drive sales growth, particularly in infant formula, while continuing to educate new mothers as a core strategy [4] - In PNC, Solid Gold will focus on high-end pet food and supplements, enhancing cross-border e-commerce efforts to sustain growth [4] Financial Position - H&H completed refinancing of 297 million USD in senior notes due in 2026, extending debt maturity and reducing overall financing costs. As of June 30, the company had cash reserves of 1.83 billion yuan [4] Leadership Perspective - The CEO emphasized the commitment to maintaining liquidity and supporting future growth while accelerating the development of the three main business segments. The multi-brand and multi-channel strategy is seen as a robust growth support system [5]

Core Insights - The nutritional supplement market is undergoing significant transformation due to rapid economic development and diverse consumer demands [1] - In 2024, the company achieved a total revenue of 13.052 billion yuan, demonstrating the effectiveness of its long-term strategy [1] - The company is actively addressing challenges posed by the transition to new national standards, paving the way for sustainable development [1] Revenue Growth - The nutritional supplement category generated revenue of 8.831 billion yuan, marking a historical high and increasing its share of total revenue from 9% a decade ago to 68% [2] - The adult nutrition care (ANC) segment achieved a year-on-year growth of 8.8%, while the pet nutrition care (PNC) segment grew by 4.4%, both reaching record revenue levels [3] Market Positioning - The company has established a solid business structure across three main segments: adult nutrition care (ANC), infant nutrition care (BNC), and pet nutrition care (PNC) [3] - The Swisse, 合生元, Zesty Paws, and Solid Gold brands are recognized leaders in their respective markets, achieving strong performance both domestically and globally [3] Strategic Developments - The 合生元 brand has strengthened its position in the ultra-premium infant formula market, with market share increasing from 12.4% to 13.3% [4] - The company is actively working on transitioning to new national standard products, expected to be completed by mid-2025, which will support future market expansion [4]